EDESA BIOTECH, INC. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- EDESA BIOTECH, INC. stock issued during period, value, stock options exercised for the quarter ending 2016-06-30 was $0.00.
- EDESA BIOTECH, INC. stock issued during period, value, stock options exercised for the quarter ending 2016-03-31 was $0.00.
- EDESA BIOTECH, INC. stock issued during period, value, stock options exercised for the quarter ending 2015-12-31 was $0.00, a 100.00% decline year-over-year.
- EDESA BIOTECH, INC. stock issued during period, value, stock options exercised for the quarter ending 2015-09-30 was $66.39K.
- EDESA BIOTECH, INC. stock issued during period, value, stock options exercised for fiscal 2020 was $11.57K.
- EDESA BIOTECH, INC. stock issued during period, value, stock options exercised for fiscal 2015 was $94.17K, a 82.70% decline from fiscal 2014.
- EDESA BIOTECH, INC. stock issued during period, value, stock options exercised for fiscal 2014 was $544.42K, a 651.93% increase from fiscal 2013.
- EDESA BIOTECH, INC. stock issued during period, value, stock options exercised for fiscal 2013 was $72.40K, a 55.73% increase from fiscal 2012.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2020-09-30 | $11.57K 10-K · filed 2020-12-07 | |
| 2016-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-08-09 | $66.39K derived: sum of 4 quarters · filed 2017-12-01 |
| 2016-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-05-09 | $66.39K derived: sum of 4 quarters · filed 2017-12-01 |
| 2015-12-31 | $0.00 10-Q · filed 2016-02-08 | $66.39K derived: sum of 4 quarters · filed 2017-12-01 |
| 2015-09-30 | $66.39K derived: 10-K 12 month − 10-Q 9 month · filed 2017-12-01 | $94.17K 10-K · filed 2017-12-01 |
| 2015-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-08-09 | |
| 2015-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-05-09 | |
| 2014-12-31 | $27.78K 10-Q · filed 2016-02-08 | |
| 2014-08-31 | $544.42K 10-K · filed 2016-12-14 | |
| 2014-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-08-10 | |
| 2014-03-31 | $238.18K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-05-11 | |
| 2013-12-31 | $137.97K 10-Q · filed 2015-02-09 | |
| 2013-08-31 | $72.40K 10-K · filed 2015-12-14 | |
| 2012-08-31 | $46.49K 10-K · filed 2014-11-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B |